Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Veronika Knoblochová"'
Autor:
Otakar Sotona, Eva Peterová, Július Örhalmi, Tomáš Dušek, Alena Mrkvicová, Veronika Knoblochová, Petr Lochman, Ondřej Malý, Jiří Páral, Jan Bureš
Publikováno v:
Acta Medica, Vol 64, Iss 3, Pp 153-157 (2021)
Introduction: The inflammatory process in Crohn’s disease (CD) is closely associated with the formation of reactive oxygen species. Antioxidant enzymes can play an important role in the outcome of CD and may influence postoperative recurrence in th
Externí odkaz:
https://doaj.org/article/bdb803adbf96474e884589ea20ed3520
Autor:
Eva Peterová, Jaroslav Chládek, Darina Kohoutová, Veronika Knoblochová, Paula Morávková, Jaroslava Vávrová, Martina Řezáčová, Jan Bureš
Publikováno v:
Acta Medica, Vol 61, Iss 1, Pp 8-16 (2018)
Analysis of Exhaled breath condensate (EBC) is a re-discovered approach to monitoring the course of the disease and reduce invasive methods of patient investigation. However, the major disadvantage and shortcoming of the EBC is lack of reliable and r
Externí odkaz:
https://doaj.org/article/9e6ac8af9f36478c8f6341ae906b55b0
Autor:
Jan Bureš, Jaroslav Květina, Věra Radochová, Miroslav Zavoral, Štěpán Suchánek, Stanislav Rejchrt, Martin Vališ, Veronika Knoblochová, Jana Žďárová Karasová, Ondřej Soukup, Darina Kohoutová
Publikováno v:
Gastroenterologie a hepatologie. 76:309-318
Summary: Introduction: Preclinical studies in experimental pigs are carried out mostly under general anaesthesia. Ketamine is commonly used for induction of anaesthesia. However, there are concerns that ketamine, an NMDA-receptor antagonist, may infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5afc2e94aaa48f3332203a52e9be6686
https://doi.org/10.48095/ccgh2022309
https://doi.org/10.48095/ccgh2022309
Autor:
Helena Medková, Blanka Kupková, Tomáš Soukup, Marcela Janebová, Jan Bures, Darina Kohoutova, Ilja Tachecí, Eva Peterová, Alice Jansová, Veronika Knoblochová
Publikováno v:
Gastroenterologie a hepatologie. 74:285-294
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21c9af85fb83d5b4d5679704190863c9
https://doi.org/10.14735/amgh2020285
https://doi.org/10.14735/amgh2020285
Autor:
Jan Bures, Paula Moravkova, Martina Řezáčová, Eva Peterová, Jaroslava Vávrová, Jaroslav Chládek, Veronika Knoblochová, Darina Kohoutova
Publikováno v:
Acta Medica, Vol 61, Iss 1, Pp 8-16 (2018)
Analysis of Exhaled breath condensate (EBC) is a re-discovered approach to monitoring the course of the disease and reduce invasive methods of patient investigation. However, the major disadvantage and shortcoming of the EBC is lack of reliable and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aceacce7dd299ba3b6798b7c833f485
https://pubmed.ncbi.nlm.nih.gov/30012244
https://pubmed.ncbi.nlm.nih.gov/30012244
Autor:
Chrysostomi Christina Tsianou, Jaroslav Kvetina, Vera Radochova, Darina Kohoutova, Stanislav Rejchrt, Martin Valis, Jana Zdarova Karasova, Ilja Tacheci, Veronika Knoblochova, Ondrej Soukup, Jan Bures
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286386 (2023)
BackgroundRivastigmine is a pseudo-irreversible cholinesterase inhibitor used for therapy of Alzheimer's disease and non-Alzheimer dementia syndromes. In humans, rivastigmine can cause significant gastrointestinal side effects that can limit its clin
Externí odkaz:
https://doaj.org/article/18153c20d6b24bac911c694b74ac254a
Autor:
Jan Bures, Ilja Tacheci, Jaroslav Kvetina, Vera Radochova, Darina Kohoutova, Martin Valis, Stanislav Rejchrt, Veronika Knoblochova, Jana Zdarova Karasova
Publikováno v:
Pharmaceuticals, Vol 14, Iss 6, p 590 (2021)
Galantamine has been used as a treatment for Alzheimer disease. It has a unique, dual mode of action (inhibitor of acetylcholinesterase and allosteric modulator of nicotinic acetylcholine receptors). Nausea (in about 20%), vomiting (10%) and diarrhoe
Externí odkaz:
https://doaj.org/article/18dd72615a184ffbb613d098ea3a205c
Autor:
Jan Bures, Ilja Tacheci, Jaroslav Kvetina, Vera Radochova, Lukas Prchal, Darina Kohoutova, Martin Valis, Martin Novak, Rafael Dolezal, Marcela Kopacova, Stanislav Rejchrt, Vit Sestak, Veronika Knoblochova, Eva Peterova, Jana Zdarova Karasova
Publikováno v:
Molecules, Vol 26, Iss 8, p 2160 (2021)
Gastrointestinal side effects of donepezil, including dyspepsia, nausea, vomiting or diarrhea, occur in 20–30% of patients. The pathogenesis of these dysmotility associated disorders has not been fully clarified yet. Pharmacokinetic parameters of d
Externí odkaz:
https://doaj.org/article/42d2564ea2aa4166bfcad13a00e081d3